University of Massachusetts Medical School Faculty Publications

Title

Clinical trials of biosimilars should become more similar

UMMS Affiliation

Division of Rheumatology, Department of Medicine

Date

1-1-2017

Document Type

Editorial

Disciplines

Rheumatology

Abstract

As many more biosimilars are in development, we recommend that clinical trial design be standardised. This standardisation could be agreed upon and overseen by regulatory agencies around the world. The introduction of consistency across clinical trials should increase confidence in these more affordable biopharmaceuticals, both within the healthcare community and among patients.

Rights and Permissions

Citation: Ann Rheum Dis. 2017 Jan;76(1):4-6. doi: 10.1136/annrheumdis-2015-208113. Epub 2016 Aug 25. Link to article on publisher's site

Related Resources

Link to Article in PubMed

Keywords

Anti-TNF, Disease Activity, Inflammation, Rheumatoid Arthritis, Treatment

PubMed ID

27566795